Lupin launches generic version of Aciphex
BALTIMORE — Indian drug maker Lupin has launched its generic version of a drug used to treat gastroesophageal reflux disease, the company said Monday.
Lupin announced the launch of rabeprazole sodium extended-release tablets in the 20-mg strength, a generic version of Eisai’s Aciphex. The Food and Drug Administration approved generic versions of Aciphex made by six companies on Friday.
Aciphex had sales of about $864.3 million during the 12-month period that ended in June, according to IMS Health.
SPCB announces first wave of certified specialty pharmacists
ALEXANDRIA, Va. — The Specialty Pharmacy Certification Board has certified nearly 50 pharmacists following the first round of exams, the group said Monday.
The SPCB announced that 49 pharmacists had earned the Certified Specialty Pharmacist accreditation after taking the exams, which were administered in October, covering intake, fulfillment, clinical management and outcomes.
"We congratulate the first wave of Certified Specialty Pharmacists as they embark on a new chapter in their careers through demonstrating their commitment and elevated skill set to employers and the greater industry by earning their certification," SPCB executive director Gary Cohen said. "Earning the CSP lets employers, patients, colleagues and other important stakeholders to the specialty pharmacy industry know that they are experts in handling specialty pharmaceuticals and have achieved a nationally recognized level of knowledge and proficiency."
PharMerica joins Surescripts network
LOUISVILLE, Ky. — Electronic prescribing network Surescripts has certified PharMerica, a chain of specialty infusion and institutional pharmacies that serve long-term care centers, for receiving orders for controlled and non-controlled substances over the Surescripts network.
PharMerica said e-prescribing would substantially reduce the amount of time it takes for patients to receive their medication while streamlining what was previously a manual, paper-based process and also streamline the process of complying with Drug Enforcement Administration policies for dispensing controlled substances in a long-term care setting.
"We are confident that bringing pharmacy industry standards to the long-term care industry will lead to faster rates of adoption," PharMerica CEO Greg Weishar said. "The Surescripts network is convenient, efficient and economical for the physician community."
Electronic prescribing has seen tremendous growth in the last decade, with the majority of retail pharmacies and prescribers set up for it. But due to Drug Enforcement Administration regulations, e-prescribing of controlled substances like opioid painkillers has been slower to take hold, but it is continuing to grow nonetheless. Currently, it is legal in 44 states, according to Surescripts.